Beyond Approval: Mastering Medical Device Post-Market Surveillance in the UAE with Pure Global's Expert Insights episode artwork

EPISODE · Sep 12, 2025 · 4 MIN

Beyond Approval: Mastering Medical Device Post-Market Surveillance in the UAE with Pure Global's Expert Insights

from MedTech Global Insights

The United Arab Emirates is a fast-growing and attractive market for MedTech innovators. However, gaining market access is only the first step. Staying in the market requires a deep understanding of the UAE's stringent and actively enforced post-market surveillance (PMS) regulations. This episode provides a detailed overview of the key PMS requirements set by the Ministry of Health and Prevention (MOHAP). We explore the essential components of a compliant PMS system, including the vigilance process, strict adverse event reporting timelines, and the implementation of Field Safety Corrective Actions. Learn why appointing a knowledgeable local representative is not just a regulatory formality but a critical component of your risk management strategy, ensuring you can respond to incidents swiftly and effectively to maintain your market presence. Case Study Highlight: Imagine your newly launched diagnostic device begins showing a pattern of minor malfunctions in the UAE's unique climate. Are you prepared to navigate MOHAP's 10-day reporting window for incidents that could potentially become serious? A failure to act correctly could escalate a manageable issue into a full product recall, jeopardizing your investment and market reputation. Key Takeaways From This Episode: 1. What are the core pillars of an effective PMS system for the UAE market? 2. How does the UAE's definition of a "reportable incident" differ from EU or US standards? 3. Why is appointing a local authorized representative more than just a regulatory checkbox? 4. What are the specific timelines for reporting different classes of adverse events to MOHAP? 5. What are the potential consequences of failing to meet UAE vigilance reporting deadlines? 6. What is a Field Safety Corrective Action, and when must it be initiated in the UAE? 7. How can you leverage post-market data from the UAE for global product improvement? 8. What key documentation must be maintained for a PMS audit by UAE authorities? Contact us for more information at [email protected] or visit https://pureglobal.com/.

Episode metadata supplied by the publisher feed · Published Sep 12, 2025

Embed this episode

NOW PLAYING

Beyond Approval: Mastering Medical Device Post-Market Surveillance in the UAE with Pure Global's Expert Insights

0:00 4:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MedTech Global Insights?

This episode is 4 minutes long.

When was this MedTech Global Insights episode published?

This episode was published on September 12, 2025.

Can I download this MedTech Global Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!